DGX News and Press, Quest Diagnostics Incorporated From 03/29/23

2023-03-29 13:26:31 ET Summary 23andMe is known around the world for its ancestry DNA genetic testing service. The company's pivot into therapeutics seems attractive. But the company saw revenue decrease from $441 million in 2019 to $272 in 2022. What's the value of having...

NORTHAMPTON, MA / ACCESSWIRE / March 29, 2023 / The Los Angeles County Department of Public Health (Public Health), with Quest for Health Equity (Q4HE), is providing laboratory blood lead testing at no charge to residents who may have been exposed to higher levels of lead and arsenic in commun...

2023-03-29 07:56:11 ET Summary GeneDx Holdings Corp. has had a dreadful performance as a stock. GeneDx's number of shares outstanding have absolutely exploded. GeneDx has a negative gross margin and is significantly burning cash. While its business model has merit, you nee...

2023-03-26 17:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Quest Diagnostics Unveils Advanced Transplant Diagnostic Services Featuring Anywhere-Access in the United States PR Newswire New capabilities include personalized patient access to Quest's national network of 2,100 patient service centers and 5 ,000 mobile and at-home phle...

First-of-Its-Kind Post-COVID-19 Panels Available at questhealth.com PR Newswire New Panels Aimed at the Millions of Americans Still Suffering From COVID-19 Side Effects SECAUCUS, N.J. , March 21, 2023 /PRNewswire/ -- The consumer-initiated testing bu...

Quest Diagnostics Completes Acquisition of Northern Light Laboratory in Maine PR Newswire SECAUCUS, N.J. , March 20, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced it has compl...

2023-03-20 04:20:31 ET Summary Quest Diagnostics core business is experiencing strong growth and has a structure that could potentially exceed market expectations. The current valuation seems very promising and making an entry at these prices I think would offer good returns. ...

Quest Diagnostics to Discuss Strategic Priorities to Drive Growth and Create Shareholder Value at 2023 Investor Day PR Newswire Updates 2023-26 compound annual growth rate (CAGR): Revenues expected to grow at mid single-digit rate; adjusted diluted earnings per share (EPS)* ex...

2023-03-10 15:00:56 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calenda...